Skip to main content
TipRanks
Go Ultimate75% OFF

Pro Medicus Limited (PME) Stock Statistics & Valuation Metrics

276 Followers

Total Valuation

Pro Medicus Limited has a market cap or net worth of AUD 21.16B. The enterprise value is AUD 21.04B.

Market Cap
AUD 21.16B
Enterprise Value
AUD 21.04B

Share Statistics

Pro Medicus Limited has 104,469,960 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
104,469,960
Owned by Insiders
46.92%
Owned by Institutions
8.80%

Financial Efficiency

Pro Medicus Limited’s return on equity (ROE) is 0.59 and return on invested capital (ROIC) is 24.67%.

Return on Equity (ROE)
0.59
Return on Assets (ROA)
0.43
Return on Invested Capital (ROIC)
24.67%
Return on Capital Employed (ROCE)
0.35
Revenue Per Employee
1.71M
Profits Per Employee
1.73M
Employee Count
153
Asset Turnover
0.43
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Pro Medicus Limited is 80.63. Pro Medicus Limited’s PEG ratio is 0.63.

PE Ratio
80.63
PS Ratio
81.76
PB Ratio
47.45
Price to FCF
180.09
Price to Operating Cash Flow
167.82
PEG Ratio
0.63

Income Statement

In the last 12 months, Pro Medicus Limited had revenue of 261.69M and earned 265.34M in profits. Earnings per share was 2.54.

Revenue
261.69M
Gross Profit
211.15M
Operating Income
196.12M
Pretax Income
377.52M
Net Income
265.34M
EBITDA
204.18M
Earnings Per Share (EPS)
2.54

Cash Flow

In the last 12 months, operating cash flow was 127.48M and capital expenditures -8.69M, giving a free cash flow of 118.80M billion.

Operating Cash Flow
127.48M
Free Cash Flow
118.80M
Free Cash Flow per Share
1.14

Dividends & Yields

Pro Medicus Limited pays an annual dividend of AUD 0.32, resulting in a dividend yield of 0.34%

Dividend Per Share
AUD 0.32
Dividend Yield
0.34%
Payout Ratio
27.65%
Free Cash Flow Yield
0.56%
Earnings Yield
1.25%

Stock Price Statistics

Beta
1.32
52-Week Price Change
-20.71%
50-Day Moving Average
177.33
200-Day Moving Average
158.88
Relative Strength Index (RSI)
62.80
Average Volume (3m)
218.19K

Important Dates

Pro Medicus Limited upcoming earnings date is Feb 16, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 17, 2026
Next Earnings Date
Feb 16, 2027
Ex-Dividend Date
Feb 25, 2026

Financial Position

Pro Medicus Limited as a current ratio of 6.82, with Debt / Equity ratio of 0.49%

Current Ratio
6.82
Quick Ratio
6.82
Debt to Market Cap
0.00
Net Debt to EBITDA
-0.71
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Pro Medicus Limited has paid 112.17M in taxes.

Income Tax
112.17M
Effective Tax Rate
0.30

Enterprise Valuation

Pro Medicus Limited EV to EBITDA ratio is 102.94, with an EV/FCF ratio of 176.92.

EV to Sales
80.32
EV to EBITDA
102.94
EV to Free Cash Flow
176.92
EV to Operating Cash Flow
164.87

Balance Sheet

Pro Medicus Limited has AUD 250.62M in cash and marketable securities with AUD 2.23M in debt, giving a net cash position of AUD 248.39M billion.

Cash & Marketable Securities
AUD 250.62M
Total Debt
AUD 2.23M
Net Cash
AUD 248.39M
Net Cash Per Share
AUD 2.38
Tangible Book Value Per Share
AUD 4.10

Margins

Gross margin is 80.69%, with operating margin of 74.94%, and net profit margin of 101.40%.

Gross Margin
80.69%
Operating Margin
74.94%
Pretax Margin
144.26%
Net Profit Margin
101.40%
EBITDA Margin
78.02%
EBIT Margin
74.94%

Analyst Forecast

The average price target for Pro Medicus Limited is AUD 219.27, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
AUD 219.27
Price Target Upside
8.24% Upside
Analyst Consensus
Moderate Buy
Analyst Count
9
Revenue Growth Forecast
22.87%
EPS Growth Forecast
130.30%

Scores

Smart Score
8
AI Score
71